Search results
Covid vaccines may have helped fuel rise in excess deaths
The Telegraph via Yahoo News· 2 days agoCovid-19 death mattered and every life deserved protection through containment measures and Covid-19...
Adults 60+ Will Have 3 RSV Vaccines to Choose From This Year
Verywell Health via Yahoo News· 13 hours agoThat way, you can have some time between shots before it’s time to get your fall flu shot and an...
A Startling New Study Found That 75% of Past COVID Patients May Suffer From This Heart Condition
Parade· 21 hours agoA new study of 200 COVID-19 patients between the ages of 18 and 83 revealed that more than 75% of...
The COVID-19 Vaccines Shouldn't Have Been Free
Reason.com via Yahoo News· 7 days agoAs it stands right now, no one is able to sue the maker of a COVID-19 vaccine should they have an adverse reaction. (Unlike standard, ...
FDA Panel Recommends New COVID Vaccines For JN.1 Lineage By Fall
Forbes· 1 day agoA Food and Drug Administration expert panel voted Wednesday to manufacture new COVID-19 vaccines to...
Fauci defends his work on COVID-19, says he has an ‘open mind’ on its origins
Oklahoma Voice via Yahoo News· 13 hours agoWASHINGTON — Dr. Anthony Fauci defended his decision-making during the COVID-19 pandemic on Monday,...
Cancer vaccine hailed as 'game-changer'
Newsweek· 6 days agoCancer patients in the U.K. are about to get personalized cancervaccines as part of a new trial. Unlike vaccines for diseases like the flu or ...
Exploring how parental decisions on vaccines can be swayed by social media
Medical Xpress· 2 days agoThe paper, "Exploring social media influences on vaccine decision-making in parents: a netnography,"...
US approves Moderna's RSV vaccine for older adults
Medical Xpress· 6 days agoAdministration on Friday approved Moderna's respiratory syncytial virus (RSV) vaccine for older adults—marking the first time any mRNA shot has been...
Moderna wins FDA approval for RSV vaccine
BioPharma Dive via Yahoo Finance· 6 days agoThe OK for mResvia adds another option for preventing RSV-related disease in older adults, one year after the agency cleared shots from GSK and Pfizer.